======= SMC6 =======
== Gene Information ==
* **Official Symbol**: SMC6
* **Official Name**: structural maintenance of chromosomes 6
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79677|79677]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96SB8|Q96SB8]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SMC6&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SMC6|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/609387|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Core component of the SMC5-SMC6 complex, a complex involved in DNA double-strand breaks by homologous recombination. The complex may promote sister chromatid homologous recombination by recruiting the SMC1-SMC3 cohesin complex to double-strand breaks. The complex is required for telomere maintenance via recombination in ALT (alternative lengthening of telomeres) cell lines and mediates sumoylation of shelterin complex (telosome) components which is proposed to lead to shelterin complex disassembly in ALT-associated PML bodies (APBs). Required for recruitment of telomeres to PML nuclear bodies. SMC5-SMC6 complex may prevent transcription of episomal DNA, such as circular viral DNA genome (PubMed:26983541). {ECO:0000269|PubMed:16810316, ECO:0000269|PubMed:17589526, ECO:0000269|PubMed:26983541}.
|SMC N|
|sex chromosome|
|interchromatin granule|
|Smc5-Smc6 complex|
|telomere maintenance via recombination|
|mitotic recombination|
|positive regulation of chromosome segregation|
|cellular senescence|
|chromosome, telomeric region|
|site of double-strand break|
|cell aging|
|intracellular|
|telomere maintenance|
|PML body|
|telomere organization|
|regulation of chromosome segregation|
|DNA recombination|
|aging|
|ubiquitin protein ligase binding|
|anatomical structure homeostasis|
|nuclear speck|
|DNA repair|
|DNA metabolic process|
|cellular response to DNA damage stimulus|
|chromosome organization|
|ATP binding|
|homeostatic process|
|cellular response to stress|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp170|Metformin 100 to 150μM on day4 R04 exp170]]|-2.18|
|[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-1.99|
|[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-1.95|
|[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|-1.84|
|[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|-1.78|
|[[:results:exp30|Rapamycin 10μM R00 exp30]]|-1.76|
|[[:results:exp34|Rotenone 20μM R00 exp34]]|1.71|
|[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|1.97|
|[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|2.62|
^Gene^Correlation^
|[[:human genes:h:hars|HARS]]|0.514|
|[[:human genes:s:smc5|SMC5]]|0.47|
|[[:human genes:n:nsmce1|NSMCE1]]|0.458|
|[[:human genes:n:nsmce2|NSMCE2]]|0.405|
Global Fraction of Cell Lines Where Essential: 32/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|3/28|
|blood|0/28|
|bone|3/26|
|breast|1/33|
|central nervous system|4/56|
|cervix|0/4|
|colorectal|1/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|1/20|
|lung|1/75|
|lymphocyte|0/16|
|ovary|1/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|2/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|2/22|
|urinary tract|2/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 478
* **Expression level (log2 read counts)**: 7.98
{{:chemogenomics:nalm6 dist.png?nolink |}}